Rupa Sridharan

Credentials: PhD

Position title: Assistant Professor


Phone: (608) 316-4422

2118 WID
33 N Orchard St
Madison, WI 53703

Sridharan Lab

Focus Groups

Signal Transduction


PhD, University of California, Los Angeles

Research Summary

Stem Cell Biology, Epigenetics of cell fate change, Induced Pluripotent Stem cells.

Research Detail

Embryonic stem (ES) cells have the ability to divide indefinitely and to differentiate into any tissue under the correct set of chemical stimuli. Transcription factor- mediated reprogramming, initially demonstrated in mouse somatic cells, is the process by which the overexpression of a few transcription factors, usually, Oct4, Sox2, c-Myc and Klf4 converts differentiated cells into induced pluripotent stem (iPS) cells. Multiple molecular and functional studies have shown that iPS cells are highly similar to ES cells. Human somatic cells can also be reprogrammed, providing iPS cells both as tools for translational research such as for in vitro drug screens and for cell replacement therapy. Only about 1 % of cells complete the reprogramming process suggesting that multiple barriers have to be overcome for this dramatic change in cell fate to occur. Research in the lab will be focused on understanding the epigenetic roadblocks to the reprogramming process to illuminate both the mechanisms that control pluripotency and the stability of the differentiated state.

Specifically, we want to answer the following questions:

  1. How do the reprogramming factors activate pluripotency loci?
  2. What controls the global chromatin structure during reprogramming?
  3. Are there common principles in the reversion of differentiation that can be applied to switching the lineage between two differentiated cell types?

Insights from these basic research studies may enable the rational development of more efficient methods of reprogramming somatic cells for use in therapeutic settings.

PubMed Search For Rupa Sridharan